FeaturedNeurologyNeurosciencePain·April 1, 2026·9 min readHigh-Potency Opioid Relieves Pain Without the RisksResearchers have engineered a novel nitazene-based opioid, DFNZ, that provides potent pain relief without causing respiratory depression or addiction. The "superagonist" drug could revolutionize treatment for chronic pain and opioid use disorder.Read More
FeaturedNeurologyNeuroscience·March 16, 2026·7 min readTurning Plastic Bottles into Parkinson’s MedicationResearchers have successfully turned discarded plastic bottles into L-DOPA, proving that plastic waste is a valuable resource for human health.Read More
FeaturedNeuroscience·March 14, 2026·9 min readMost Insomnia Meds Don’t Worsen Sleep ApneaNew research identifies which insomnia medications protect the breath while promoting rest, debunking long-held fears about "sleep-inducing" drugs.Read More
FeaturedNeuroscience·March 10, 2026·13 min readWhy GLP-1 Drugs Affect Men and Women DifferentlyA new atlas reveals that GLP-1—the backbone of blockbuster weight-loss drugs—is mapped differently in the male and female brain.Read More
FeaturedNeurologyNeuroscience·March 6, 2026·9 min read70-Year-Old Drug Could Stop Epilepsy SeizuresScientists discover that stabilizing a single ion transporter can flip the switch from seizure activity to healthy brain inhibition.Read More
FeaturedNeurologyNeuroscience·March 2, 2026·7 min readBeyond Weight Loss: Ozempic Linked to Migraine ReductionUnexpected relief. New research shows that patients taking GLP-1 drugs for diabetes or weight loss also experience fewer emergency room visits and need fewer medications for their chronic migraines.Read More
FeaturedNeurologyNeuroscience·March 2, 2026·9 min readLow-Dose Lithium May Shield Against Verbal Memory LossA new pilot study reveals that low-dose lithium may act as a neuroprotective shield, slowing verbal memory loss in patients at risk for Alzheimer’s.Read More
FeaturedNeuroscience·February 21, 2026·7 min readMounjaro’s Active Ingredient Slashes Alcohol IntakeFrom weight loss to sobriety. New research reveals how the active ingredient in Mounjaro "mutes" the brain's reward system to slash alcohol cravings.Read More
FeaturedNeurologyNeuroscience·February 17, 2026·6 min readBrain Swelling Reveals Alzheimer’s Treatment SuccessIt’s the side effect every Alzheimer’s patient fears, but it might actually be a sign of success. New research shows brain swelling is tied to better plaque clearance.Read More
FeaturedNeurosciencePsychology·February 13, 2026·7 min readGlaucoma Drug Repurposed to Block Opioid Cravings and RelapseAn old drug for glaucoma might be the key to stopping opioid relapse. New research shows acetazolamide "resets" the brain's reward center to block cravings.Read More
FeaturedNeuroscienceVisual Neuroscience·February 13, 2026·6 min readPsychedelics Shift Brain Networks, Sparking Memory-Driven PerceptionNew neuroscience research shows psychedelics alter brain waves to suppress incoming visual input and boost memory-linked circuitry. This rewiring helps explain how vivid hallucinations arise, and highlights how these drugs might be used therapeutically.Read More
FeaturedGeneticsNeurologyNeuroscience·February 12, 2026·8 min readNew Drug Target Could Freeze Alzheimer’s in Its TracksIs the IDOL enzyme the key to stopping Alzheimer's? New research shows that blocking this single target can dissolve brain plaques and boost cognitive resilience. By lowering the brain's "strongest risk factor" protein, scientists have found a new way to keep neurons communicating even under attack.Read More
